The Annual Symposium of the Society for the Study of Inborn Errors of Metabolism took place in Porto, Portugal this year. A number of people from the Charlie consortium presented at the SSIEM 2024.

On the photo Prof Clara van Karnebeek, chair of the Charlie consortium presenting “New treatment for PDE-ALDH7A1: First proof-of-principle of upstream enzyme inhibition in mouse”.

Parisa Paydar from the University of Luxembourg presented: “Novel in vivo models to investigate inborn errors of lysine catabolism” and Alex Garanto presented a poster.

Hanka Dekker, Director of the Dutch Association for Adults and Children with a Metabolic Disorder (VKS) in the Netherlands was speaker in the Patient Advocacy Groups Session Cultural Differences of Living with an IMD and panelist.

For the full program and more information on the SSIEM 2024 visit the website: https://www.ssiem2024.org/programme/programme